A magnetic force for healthcare

Currently, many drugs work by blocking substances in the body. But what if it was possible to, not just block those substances, but remove them entirely?
That's the goal of hemotune: a Swiss startup business behind a groundbreaking blood-purification platform called "HemoSystem".
HemoSystem uses small magnetic beads that select, bind to and remove large biomolecules in the blood. The system can also deploy different beads for different targets, removing various substances at the same time – an impossible task for today's medicines.
hemotune is developing its first treatment, which aims to restore immunity in patients suffering from sepsis. Every year, sepsis affects almost 50 million people and leads to around 11 million deaths.¹ For these reasons, the World Health Organization declared sepsis a global health priority in 2017.
Through its precision-medicine blood purification, hemotune aims to reduce sepsis-related mortality, hospital stays and costs.
Lukas Langenegger co-founded hemotune in 2017 to achieve his ambition of using technology to solve global challenges. The company has received prestigious plaudits and awards, including Forbes magazine's number one spin-off to watch; winner of the German Innovation Award 2022; finalist of the Swiss Economic Award 2022; and winner of Frost & Sullivan's 2022 Technology Innovation Leadership Award.

¹ https://www.global-sepsis-alliance.org/sepsis

Legal note

This material is for informational and educational purposes only and should not be relied upon as investment advice or the basis for making any investment decisions. It is not intended to be regarded as investment research, a sales prospectus, as an offer, or a solicitation of an offer, to buy or sell any product or other specific service. The views and opinions expressed in this material are those of the respective speakers/authors and may differ or be contrary to opinions expressed by UBS Switzerland AG, its subsidiaries or affiliates ("UBS"). Neither UBS nor any of its directors, officers, employees or agents accepts any liability for any loss or damage arising out of the use of all or any part of this material or reliance upon any information contained or provided herein. The information and data presented by the speaker/author may be deemed reliable; however, their accuracy and completeness is not guaranteed or verified by UBS and providing you with this information is not to be considered a solicitation with respect to the purchase or sale of any securities, investments, strategies or products that may be mentioned. The information, data and any opinions expressed in this material are current as of the date of publication of this material and are subject to change without notice. UBS is under no obligation to update or keep current the information contained in this material. The viewer/reader should not construe the contents of this material as legal, tax, accounting, regulatory, or other specialist or technical advice or services, or investment advice or a personal recommendation or a substitute for the exercise of his/her own judgment. Viewers/readers should refer to their own professional advisors and consultants for advice.

Important information in the event this document is distributed to US Persons or into the United States:

Important information about brokerage and advisory services. As a firm providing wealth management services to clients, UBS Financial Services Inc. offers investment advisory services in its capacity as an SEC-registered investment adviser and brokerage services in its capacity as an SEC-registered broker-dealer. Investment advisory services and brokerage services are separate and distinct, differ in material ways and are governed by different laws and separate arrangements. It is important that you understand the ways in which we conduct business and that you carefully read the agreements and disclosures that we provide about the products or services we offer. For more information, please review client relationship summary provided at ubs.com/relationshipsummary.

No affiliation, association, sponsorship or endorsement is suggested or implied by UBS to any person, entity, company or organization appearing, featured or mentioned in this material.

UBS specifically prohibits the redistribution or reproduction of this material in whole or in part without the prior written permission of UBS. UBS accepts no liability whatsoever for any claims or lawsuits from any third parties arising from the use or distribution of this material.

USA: Distributed to US persons by UBS Financial Services Inc., a subsidiary of UBS AG and a member of FINRA/SIPC. UBS Securities LLC is a subsidiary of UBS AG and an affiliate of UBS Financial Services Inc.

We envision a future where precision blood purification is an indispensable tool for improving patient outcomes, saving lives and containing global healthcare costs.

hemotune works towards this UN Sustainable Development Goal:

Other Global Visionaries you might find interesting:

Or you can view and select from all of our Global Visionaries

Visions